Noordwijkerhout

NOORDWIJKERHOUT, Netherlands and WEBSTER, Texas, May 17, 2011 - IDEV Technologies announced today that data from a long lesion study of 182 patients with significantly diseased superficial femoral arteries and popliteal arteries showed high patency rates and no stent fractures after treatment with the SUPERA VERITAS(R) Peripheral Vascular Stent System.